Cytek Biosciences, Inc. (CTKB)☆SHARE ON XDOWNLOAD PNGHealthcare$4.44-7.69%CloseBUYRECOVERY · day 11CTKB▲ BUY$4.44-7.69%☆OverviewFinancialsFinEarningsEarnAnalyst & RatingsAnalystNewsHolders & ETFsHoldOptionsKey statsMarket cap$573MAvg volume1.2MBeta1.17P/E (TTM)-7.13Prediction marketsKalshi · Polymarket · … linkedFull prediction markets →Loading markets…Company newsglobenewswire.com · 4d agoJury Finds in Cytek's Favor on Three of Four Asserted Claims; Company to Challenge Remaining Findingseekingalpha.com · 19d agoCytek Biosciences, Inc. (CTKB) Q2 2026 Earnings Call Transcriptmarketbeat.com · 20d agoCytek Biosciences Q2 Earnings Call Highlightszacks.com · 20d agoCytek Biosciences, Inc. (CTKB) Reports Q2 Loss, Tops Revenue Estimatesglobenewswire.com · 20d agoCytek Biosciences Reports Second Quarter 2026 Financial Resultszacks.com · 27d agoAnalysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out forzacks.com · 33d agoCSBR vs. CTKB: Which Life Sciences Stock Has Better Long-Term Upside?globenewswire.com · 34d agoCytek Biosciences to Report Second Quarter 2026 Financial Results on August 5, 2026globenewswire.com · 41d agoCytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagementglobenewswire.com · 76d agoCytek Biosciences to participate at the Singular Research's Las Vegas Invitational Conferenceglobenewswire.com · 84d agoCytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026Market news & ticker search · RSS for CTKB
